Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer’s disease

Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer’s disease

Abstract Background Progressive neuronal death is the key pathological feature of Alzheimer’s disease (AD). However, the molecular mechanisms underlying the neuronal death in AD patients have not been fully elucidated. Necroptosis reportedly activates and induces neuronal death in patients with Alzh...

Full description

Bibliographic Details
Main Authors:	Yue Dong, Hanqiao Yu, Xueqi Li, Kelong Bian, Yayuan Zheng, Mingrui Dai, Xuejian Feng, Yao Sun, Yu He, Bin Yu, Haihong Zhang, Jiaxin Wu, Xianghui Yu, Hui Wu, Wei Kong
Format:	Article
Language:	English
Published:	BMC 2022-08-01
Series:	Journal of Neuroinflammation
Subjects:	Hyperphosphorylated tau Neuronal death Necroptosis Inflammation NF-κB Alzheimer’s disease
Online Access:	https://doi.org/10.1186/s12974-022-02567-y

Similar Items

Neuroprotective effects of tenuigenin on neurobehavior, oxidative stress, and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats
by: Xiao-Bo Huang, et al.
Published: (2018-01-01)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
by: Jin Miao, et al.
Published: (2019-03-01)

Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort
by: Dandan Chen, et al.
Published: (2023-06-01)

Hyperphosphorylation-induced tau oligomers
by: Khalid eIqbal, et al.
Published: (2013-08-01)

Morin attenuates tau hyperphosphorylation by inhibiting GSK3β
by: Eun Ji Gong, et al.
Published: (2011-11-01)

Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology
by: Antoine Duquette, et al.
Published: (2021-01-01)

Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models
by: Nigel C. Jones, et al.
Published: (2012-03-01)

Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2018-03-01)

Hyperphosphorylation of Tau Protein in Hippocampus of Central Insulin-Resistant Rats is Associated with Cognitive Impairment
by: Dantao Peng, et al.
Published: (2013-11-01)

Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline
by: Amelia D. Hines, et al.
Published: (2023-04-01)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
by: Yan Zhou, et al.
Published: (2018-02-01)

Berberine Reduces Aβ42 Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress
by: Yue Wu, et al.
Published: (2021-07-01)

Structural Analysis and Conformational Dynamics of Short Helical Hyperphosphorylated Segments of Tau Protein (Sequence 254–290) in Alzheimer’s Disease: A Molecular Dynamics Simulation Study
by: Mozhgan Alipour, et al.
Published: (2022-08-01)

The Role of Traditional Chinese Medicine Natural Products in β-Amyloid Deposition and Tau Protein Hyperphosphorylation in Alzheimer’s Disease
by: Yan H, et al.
Published: (2023-11-01)

A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau
by: Yang Gao, et al.
Published: (2023-11-01)

Targeting Tau to Treat Clinical Features of Huntington's Disease
by: Maria Masnata, et al.
Published: (2020-11-01)

Neurons Expressing Pathological Tau Protein Trigger Dramatic Changes in Microglial Morphology and Dynamics
by: Rahma Hassan-Abdi, et al.
Published: (2019-11-01)

GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions
by: Huazhang Zhu, et al.
Published: (2018-11-01)

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy
by: John David Eun, et al.
Published: (2022-07-01)

Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models
by: Yulian Zou, et al.
Published: (2021-12-01)

Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes
by: M.A Kurt, et al.
Published: (2003-10-01)

Necroptosis Mediates Cigarette Smoke-Induced Inflammatory Responses in Macrophages
by: Wang Y, et al.
Published: (2020-05-01)

A nonhuman primate model with Alzheimer’s disease-like pathology induced by hippocampal overexpression of human tau
by: Zhouquan Jiang, et al.
Published: (2024-01-01)

Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease
by: Jangampalli Adi Pradeepkiran, et al.
Published: (2019-03-01)

Indirubin-3′-monoxime suppresses amyloid-beta- induced apoptosis by inhibiting tau hyperphosphorylation
by: Shu-gang Zhang, et al.
Published: (2016-01-01)

Tau Pathology in Parkinson's Disease
by: Xue Zhang, et al.
Published: (2018-10-01)

Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells
by: Yao K, et al.
Published: (2019-01-01)

Silencing of TRAF5 enhances necroptosis in hepatocellular carcinoma by inhibiting LTBR-mediated NF-κB signaling
by: Guolin Wu, et al.
Published: (2023-06-01)

Development of p-Tau Differentiated Cell Model of Alzheimer’s Disease to Screen Novel Acetylcholinesterase Inhibitors
by: Giuseppe Uras, et al.
Published: (2022-11-01)

Long-Term High-Fat Diet Consumption Induces Cognitive Decline Accompanied by Tau Hyper-Phosphorylation and Microglial Activation in Aging
by: Zheng Liang, et al.
Published: (2023-01-01)

The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice
by: Aviva eTolkovsky, et al.
Published: (2015-05-01)

Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
by: Xiao-bo Yang, et al.
Published: (2022-01-01)

Pathological Human Tau Induces Alterations in the Brain Insulin Signaling Cascade
by: Abdeslem El Idrissi, et al.
Published: (2022-02-01)

Tau phosphorylation and cochlear apoptosis cause hearing loss in 3×Tg-AD Mouse Model of Alzheimer's Disease
by: Sheue-Er Wang, et al.
Published: (2021-01-01)

The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer’s disease
by: Yao Sun, et al.
Published: (2020-02-01)

Astaxanthin Ameliorated Parvalbumin-Positive Neuron Deficits and Alzheimer’s Disease-Related Pathological Progression in the Hippocampus of AppNL-G-F/NL-G-F Mice
by: Nobuko Hongo, et al.
Published: (2020-03-01)

Curcuminoids and resveratrol as anti-Alzheimer agents
by: Oliver B. Villaflores, et al.
Published: (2012-12-01)

Untangling Tau: Molecular Insights into Neuroinflammation, Pathophysiology, and Emerging Immunotherapies
by: Ryder Davidson, et al.
Published: (2023-11-01)

Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development
by: Zeba Mueed, et al.
Published: (2019-01-01)

Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway
by: Xiaonan Kang, et al.
Published: (2023-09-01)